Blog
17 March 2026
New Oral Drug REX-8756 Begins Trials for Inflammatory Skin Diseases
REX-8756, a new oral drug targeting STAT6, begins human trials for inflammatory skin diseases like atopic dermatitis. Explore the latest...
Read more
Photodynamic Therapy Benefits: A Practical Approach to Treating Actinic Keratoses
Discover the practical benefits of photodynamic therapy for treating actinic keratoses—effective, field-directed care that improves patient outcomes and compliance.
16 03 2026
Read more
Topical Ivermectin Boosts KTP Laser Results for Rosacea Redness and Lesions
Topical ivermectin 1% cream boosts KTP laser results for rosacea redness and lesions, offering a safe, effective combo to improve...
15 03 2026
Read more
Transdermal Botulinum Toxin Cuts Acne-Related Oil Production by 40%
Discover how transdermal botulinum toxin cuts acne-related oil production by 40%, offering a needle-free, effective solution for oily, acne-prone skin.
14 03 2026
Read more
New Study Shows ALA-PDT Effectively Treats Bowen’s Disease in Chinese Patients
New study reveals 5-aminolevulinic acid photodynamic therapy (ALA-PDT) as an effective, noninvasive treatment for Bowen’s disease in Chinese patients.
13 03 2026
Read more
How Patch Testing Uncovers Allergens Causing Hand and Foot Eczema
Discover how patch testing helps identify allergens causing hand and foot eczema, improving diagnosis and treatment for lasting skin relief.
15 03 2026
Read more
New Gene Test Helps Tailor Systemic Treatment for Atopic Dermatitis
Discover how the new AdvanceAD-Tx 487-gene test personalizes systemic treatment for moderate to severe atopic dermatitis, improving patient outcomes.
13 03 2026
Read more
New Cream Shows Promise in Reducing Acne and Hyperpigmentation in Skin of Color
Discover a new cream that effectively reduces acne and stubborn hyperpigmentation in skin of color, improving skin health and confidence.
13 03 2026
Read more
Effective Treatments and Insights for Managing Type 2 Inflammation
Discover effective treatments and expert insights for managing type 2 inflammation in atopic dermatitis, psoriasis, and chronic skin conditions.
10 03 2026
Read more